ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Regístrate

¿Ya eres miembro? Iniciar sesión

Los Principales Corredores en Línea

Más Corredores en Línea

Datos
Noticias
Herramientas
Mercados
Descubrir

Hot Features

Follow Feed

Conéctese con traders e inversores en nuestra comunidad Follow Feed.

Flujo de Opciones

Explora datos de opciones completos y utiliza filtros avanzados con Options Flow.

Monitor

Organiza y monitorea tu lista de seguimiento de acciones y activos con Monitor.
Iniciar Sesión Premium IconPremium Help Menu
S&P 500
5,354.03
1.18%
Dow Jones
38,807.33
0.25%
US Dollar vs MXN
17.4691
-0.28%
Brent Oil
78.635
0.10%
Bitcoin
71,163.50
0.12%
Registration Strip Icon for discussion Regístrate para interactuar en nuestros foros activos para discutir con inversores de ideas afines.
Regístrate
  1. Inicio
  2. Invertir
  3. Acciones
  4. Estados Unidos
  5. NASDAQ
  6. Personalis Inc (PSNL)

  7. Personalis Inc (PSNL) Noticias

PSNL

Personalis (PSNL)

Personalis Inc
Fecha:
Ordernar por:
 Showing the most relevant articles for your search:NASDAQ:PSNL
FechaHoraFuenteTítuloSímboloCompañía
04/06/202415:05Business WireASCO Data Highlights NeXT Personal® Ultra-sensitive MRD Performance in Early-stage Breast Cancer Recurrence Detection and Immunotherapy MonitoringNASDAQ:PSNLPersonalis Inc
31/05/202408:05Business WirePersonalis Announces Start of Cancer MRD Testing Commercialization Collaboration with TempusNASDAQ:PSNLPersonalis Inc
22/05/202408:05Business WirePersonalis Announces Podium Presentations and Abstracts Accepted at ASCO 2024NASDAQ:PSNLPersonalis Inc
21/05/202420:14Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:PSNLPersonalis Inc
21/05/202415:12Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:PSNLPersonalis Inc
17/05/202415:05Business WirePersonalis Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)NASDAQ:PSNLPersonalis Inc
08/05/202415:01Business WirePersonalis Reports First Quarter 2024 Financial ResultsNASDAQ:PSNLPersonalis Inc
24/04/202415:01Business WirePersonalis to Announce First Quarter 2024 Financial ResultsNASDAQ:PSNLPersonalis Inc
28/03/202415:01Business WirePersonalis to Present at the 23rd Annual Needham Virtual Healthcare ConferenceNASDAQ:PSNLPersonalis Inc
28/03/202408:00Business WireData Showcasing NeXT Personal MRD Test to be Presented at the 2024 American Association for Cancer Research (AACR) Annual MeetingNASDAQ:PSNLPersonalis Inc
26/03/202408:00Business WirePersonalis Announces Publication Validating NeXT Personal® Test for Ultra-sensitive MRD Detection and Cancer Treatment Response MonitoringNASDAQ:PSNLPersonalis Inc
28/02/202415:01Business WirePersonalis Reports Fourth Quarter and Full Year 2023 Financial ResultsNASDAQ:PSNLPersonalis Inc
14/02/202415:01Business WirePersonalis to Announce Fourth Quarter and Full Year 2023 Financial ResultsNASDAQ:PSNLPersonalis Inc
31/01/202415:01Business WirePersonalis to Participate at Upcoming Investor ConferencesNASDAQ:PSNLPersonalis Inc
30/01/202408:00Business WirePersonalis and ClearNote Health Announce Partnership to Advance Epigenomic TechnologyNASDAQ:PSNLPersonalis Inc
29/01/202415:00Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:PSNLPersonalis Inc
16/01/202408:05Business WirePersonalis Announces Medicare Coverage for NeXT Dx(R) Comprehensive Genomic Tumor Profiling AssayNASDAQ:PSNLPersonalis Inc
09/01/202423:15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:PSNLPersonalis Inc
05/01/202408:05Business WirePersonalis Reports Preliminary Fourth Quarter and Full Year 2023 Revenue and Cash BalanceNASDAQ:PSNLPersonalis Inc
21/12/202316:15Edgar (US Regulatory)Form S-3 - Registration statement under Securities Act of 1933NASDAQ:PSNLPersonalis Inc
05/12/202315:07Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:PSNLPersonalis Inc
05/12/202315:05Edgar (US Regulatory)Form SC 13G - Statement of acquisition of beneficial ownership by individualsNASDAQ:PSNLPersonalis Inc
04/12/202308:15Business WirePersonalis Extends Cash Position Into 2026, Provides Update on Key InitiativesNASDAQ:PSNLPersonalis Inc
28/11/202315:15Business WirePersonalis and Tempus Enter into a Strategic Collaboration to Advance Cancer TestingNASDAQ:PSNLPersonalis Inc
07/11/202315:11Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:PSNLPersonalis Inc
07/11/202315:01Business WirePersonalis Reports Third Quarter 2023 Financial ResultsNASDAQ:PSNLPersonalis Inc
26/10/202307:15Business WirePersonalis Launches NeXT Personal® Dx for Early Access Clinical Use in Residual Disease and Recurrence Detection in CancerNASDAQ:PSNLPersonalis Inc
24/10/202315:01Business WirePersonalis to Announce Third Quarter 2023 Financial ResultsNASDAQ:PSNLPersonalis Inc
21/10/202303:25Business WireAnalysis from TRACERx Study Reveals More Sensitive and Earlier ctDNA Detection in Lung Cancer Patients by Personalis' MRD TechnologyNASDAQ:PSNLPersonalis Inc
19/10/202306:15Business WirePersonalis Announces Late-Breaking NeXT Personal Abstract and Proffered Paper Presentation at ESMO 2023NASDAQ:PSNLPersonalis Inc
 Showing the most relevant articles for your search:NASDAQ:PSNL

Su Consulta Reciente

TSXV
BES
Braille Energy Systems
TSXV
MDX
Medx Health
NYSE
BMO
Bank of Montreal
EU
BNPGX
BNP Paribas Arbitrage Is...
UNSW3
HOFFETH
Hoff Coin
TSXV
BML
Barker Minerals
EU
PEOWP
Banque Palatine null
BIT
F20807
Vontobel Financial Produ...
BIT
1DB1
Deutsche Boerse
BIT
UV8CHH
UniCredit Bank
BIT
P1JO70
BNP Paribas Issuance BV
AMEX
BBC
Virtus LifeSci Biotech C...
NYSE
AQN
Algonquin Power
ASX
WMLNA
Woomera Mining
NASDAQ
GFLS
Greater Community Bancorp
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

México
Empresa
Negocios
Popular
Obtener la aplicación
App Store
Google Play

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones

© 2024 ADVFN PLC - Todos los derechos reservados